Showing results (391-400 of 3,384) with videos related to

Sort By:
Pageof 339
CNS Neuroscience & Therapeutics|August 29, 2009
The impact of nonclinical factors on care use for patients with depression: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorderDouglas E Feltner, Jane Harness, Jerri Brock, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsyDimitri De Bundel, Ilse Smolders, Patrick Vanderheyden, et al.
CNS Neuroscience & Therapeutics|June 18, 2010
Antidepressant-induced suicidality: an updateRoy R Reeves, Mark E Ladner
CNS Neuroscience & Therapeutics|June 18, 2010
Dimebolin in dementiaDeepak Sachdeva, Alistair Burns
CNS Neuroscience & Therapeutics|June 18, 2010
Apoptosis-inducing factor and cyclophilin A cotranslocate to the motor neuronal nuclei in amyotrophic lateral sclerosis model miceHirotaka Tanaka, Hiroki Shimazaki, Masataka Kimura, et al.
CNS Neuroscience & Therapeutics|May 26, 2010
UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptorGirolamo Calo', Anna Rizzi, Carlo Cifani, et al.
CNS Neuroscience & Therapeutics|June 22, 2010
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?Alessandro Martorana, Zaira Esposito, Giacomo Koch
CNS Neuroscience & Therapeutics|September 30, 2010
Sevoflurane postconditioning ameliorates oxygen-glucose deprivation-reperfusion injury in the rat hippocampusSheng Peng, Pramood Kalikiri, George Mychaskiw, et al.
CNS Neuroscience & Therapeutics|April 22, 2010
Imidazolium salt (DBZIM) reduces gliosis in mice treated with neurotoxicant 2'-CH(3) -MPTPGideon Ho, Saravana Kumar, Zhiyuan Ke, et al.
Pageof 339